Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Thrombocytopenia due to platelet alloimmunization

Known as: Immune Thrombocytopenia, Thrombocytopenia (due to): platelet alloimmunization, Thrombocytopenia Due to Immune Destruction 
A general class of thrombocytopenia due to immune destruction of platelets. It includes idiopathic thrombocytopenic purpura, as well as immune… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
In a previous publication on new terminology, definitions, and outcome criteria for immune thrombocytopenia (ITP), the… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated platelet destruction and decreased platelet… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2012
Review
2012
The paradigm for managing primary immune thrombocytopenia (ITP) in adults has changed with the advent of rituximab and… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Romiplostim, a thrombopoietin-mimetic peptibody, increases and maintains platelet counts in adults with immune thrombocytopenia… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Severe thrombocytopenia is a major risk factor for hemorrhage, but platelet function and bleeding risk at low platelet… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2010
Review
2010
Previously published guidelines for the diagnosis and management of primary immune thrombocytopenia (ITP) require updating… Expand
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Previous observational studies suggest that rituximab may be useful in the treatment of primary immune thrombocytopenia (ITP… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Romiplostim is a thrombopoietin receptor agonist that increases platelet counts in patients with chronic immune thrombocytopenia… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BackgroundInterleukin-21 (IL-21) is critical in the development of autoimmune diseases. The role of IL-21 in the pathogenesis of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2006
Review
2006
Evans syndrome is an uncommon condition defined by the combination (either simultaneously or sequentially) of immune… Expand
  • table I
  • figure 1
  • table II
  • table III
  • table IV
Is this relevant?